Skip to content

Novel Objective Digital Biomarkers for Assessing Sub-clinical Mood Disturbances in the Singaporean Population

Novel Objective Digital Biomarkers for Assessing Sub-clinical Mood Disturbances in the Singaporean Population

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06115590
Enrollment
120
Registered
2023-11-03
Start date
2023-08-24
Completion date
2024-02-18
Last updated
2024-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mood

Keywords

Digital Biomarkers, Mood, Stress, Mental Health

Brief summary

The investigators aim to assess the relationship between objectives markers (of physiological reactivity) recorded using a smartwatch and self-reported subjective outcomes measured using standardized and non-standardized questionnaires recorded in an eDiary; with stress as the model for our assessment utilizing the validated PSS-10 questionnaire. As personal characteristics such as personality traits, resilience, and grit have been shown to modulate reactivity and mental health status, the investigators aim to explore the modulation of the study outcomes by such personality factors. Furthermore, the investigators aim to explore the association of the study outcomes with the composition and functional potential of the gut microbiome. Finally, the investigators aim to explore the effects of a nutritional intervention on our outcome measures. Participants will participate in a decentralized, parallel-group study with a mixed design lasting 8 days (excluding screening and enrollment). A total of 120 participants are divided into low-stress(n=40), and elevated-stress groups (n=80) based on their perceived stress score (PSS-10, cut-off score 13). A subgroup of elevated-stress participants (n=40) will be administered a nutritional intervention for 3 days. Their responses will be compared to another subgroup of elevated-stress participants (n=40) without intervention.

Interventions

DIETARY_SUPPLEMENTNutritional supplement

Nutritional intervention hypothesized to have an acute anxiolytic effect

Sponsors

OBVIO HEALTH USA, Inc.
CollaboratorUNKNOWN
Institute for Human Development and Potential (IHDP), Singapore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

8-day parallel-group design with decentralized data collection

Eligibility

Sex/Gender
ALL
Age
21 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged 21 to 30 years * Own and uses a smartphone that is capable of running the study applications * Have access to the internet * Adequate fluency in the English language to understand the informed consent process, study instructions and study assessments * Sufficient vision and hearing to complete study procedures * Willing to commit to about 20 minutes of assessments each day for a period of 8 days * Willing to wear selected study devices 24 hours/day; 7-days per week with only occasional relief * Willing and able to participate and to give written informed consent

Exclusion criteria

* Past (\< 6 months prior to the study) or current neurological or psychiatric condition * Past (\< 3 months prior to the study) or current use of psychoactive medication * Having received antibiotic treatment \< 4 weeks prior to the study * Present or past history of alcohol or drug addiction and/or recreational drug use * Maltodextrin allergy * Members of the research team or their immediate family members. An immediate family member is defined as spouse, parent, child, or sibling, whether biological or legally adopted * Women participants who are currently pregnant or have been pregnant in past 6 months

Design outcomes

Primary

MeasureTime frameDescription
State Trait Anxiety Inventory (STAI-6) 237 daysThe STAI-6 is a validated short-form version (6 items) of the 40-item STAI questionnaire, measuring current anxiety symptoms on a 4-point Likert scale. Total score is calculated (range 6-24). This questionnaire will be completed daily at 1 pm.
Depression Anxiety and Stress Scale 21 (DASS-21)7 daysThe Depression, Anxiety and Stress Scale - 21 Items (DASS-21) is a set of three self- report scales designed to measure the emotional states of depression, anxiety and stress in clinical and non-clinical populations. Each of the three DASS-21 scales contains 7 items that are scored on a 4-point Likert scale (0-3). In the current study a modified version is used where subjects rate their symptoms over the past 24 hours, rather than 1 week. This questionnaire will be completed daily at 9 pm.

Secondary

MeasureTime frameDescription
Respiratory rate7 daysRespiratory rate (breaths per minute) is measured using a Fitbit Sense 2 smart watch.
Heart rate7 daysHeart rate (beats per minute) is continuously measured using a Fitbit Sense 2 smart watch.
Sleep7 daysSleep duration (minutes) and quality are measured using a Fitbit Sense 2 smart watch.
Ecological Momentary Assessment7 daysIn the smartphone application, subject will be prompted four times a day with the following statements. The EMA assessment will occur daily at 9.00 am, 1.00 pm, 5.00 pm, 9.00 pm. Subjects are asked to indicate their current state on a VAS (Visual analog Scale). The score in the scale ranges from 0 to 100. 0 being Not at all and 100 being Very Much. The participants will be asked to respond to the following questions: Right now, I feel mentally sharp - to assess perception of cognitive ability Right now, I feel fatigued - to assess fatigue/exhaustion directly Right now, I feel stressed - to assess stress Right now, I feel nervous - to assess nervousness/tension Right now, I feel depressed - to assess depression Right now, I am in a good mood - to assess joy Right now, I feel thirsty - to assess level of thirst Right now, I feel hungry - to assess level of hunger I slept well last night - to assess subjective sleep quality
Electrodermal activity (EDA)7 daysIn four user-initiated 2-min sessions per day, Electrodermal activity is measured via a Fitbit Sense 2 smart watch.
Blood oxygenation level (SpO2)7 daysBlood oxygenation level (%) is measured using a Fitbit Sense 2 smart watch.
Activity7 daysActivity level, including #steps, distance traveled, and floors climbed, is measured using a Fitbit Sense 2 smart watch.

Other

MeasureTime frameDescription
stool microbiome functional potentialbaselineIn addition to mapping the taxonomic abundance, the gut microbiome functional potential will be analysed using Biobakery analysis tools.
Stool microbiome compositionbaselineStool samples will be collected at home on the first test day and analyzed for gut microbiome composition using shotgun metagenomic sequencing.

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026